Fig. 5From: Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cellsThe effect of BH3 mimetic combinations on PARP cleavage . The indicated cells were exposed to 66 μM carboplatin or the indicated BH3 mimetic for 48 h (doses as indicated in Methods) and PARP cleavage assessed by immunoblotting. The results are representative of 3 experimentsBack to article page